January 29, 2021

Immunodiagnostics Market – Industry Trends - Forecast to 2026 with key market like Hoffmann-La Roche Ltd, Danaher., Adaptive Biotechnologies., QIAGEN, AMARANTUS BIOSCIENCE HOLDINGS, INC., AESKU.GROUP GmbH & Co. KG

Immunodiagnostics Market By Product (Reagents, Instruments, Software & Services), Technology (ELISA, CLIA, RIA, FIA, Rapid Test, Others), End User (Clinical Laboratories, Hospitals, Academic & Research Centers, Pharmaceutical & Biotechnology Industry, Diagnostic Centers, Others), Application (Oncology & Endocrinology, Hepatitis & Retrovirus Testing, Infectious Disease Testing, GI Stool Testing, Autoimmune Disorders, Bone & Mineral Diseases, Cardiac Biomarkers, Others), Type (Immunodiagnostic Instruments, Immunoassays), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026

Market Analysis: Global Immunodiagnostics Market

Global immunodiagnostics market is expected to rise from to an estimated value of USD 24.89 billion by 2026 registering a substantial CAGR of 7.80% in the forecast period of 2021-2026. This rise in the market can be attributed to rising prevalence of chronic diseases and technological advancements.

Download Full Sample Report Of Immunodiagnostics Market @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-immunodiagnostics-market

Market Definition: Global Immunodiagnostics Market

Immunodiagnostics is a diagnostic method that uses antigen-antibody reactions to measure the presence of molecules in biological fluids.  It is used primarily for detecting and diagnosing infectious diseases, chronic diseases (cancer, cardiovascular diseases), autoimmune disease, hormonal disorder etc. These tests are also used to distinguish between compatible blood types. They provide precise, quick and accurate results and hence are gaining importance.

Market Drivers

Growing ageing & geriatric population would also boost the growth of this market as they are more prone to chronic and infectious diseases

Rising need for correct, error free and speedy diagnostic tests

Growing awareness regarding the benefits of immunodiagnostics drives the growth of this market

Rising adoption of point of care testing (POCT) drives the demand for this market

Rising volumes of test due to the integration of laboratories would boost the growth of this market

Market Restraints

Stringent regulations imposed by the government hinder the growth of this market

Cost of immunodiagnostics being expensive restrains its growth

Segmentation: Global Immunodiagnostics Market

By Product

·       Reagents

·       Instruments

·       Software & Services

By Technology

·       Enzyme-Linked Immunosorbent Assay (ELISA)

·       Chemiluminescence Immunoassay (CLIA)

·       Radioimmunoassay (RIA)

·       Fluorescence Immunoassay (FIA)

·       Rapid Tests

·       Others

By End User

·       Clinical Laboratories

·       Hospitals

·       Academic & Research Centers

·       Pharmaceutical & Biotechnology Industry

·       Diagnostic Centers

·       Others

By Application

·       Oncology & Endocrinology

·       Hepatitis & Retrovirus

·       Infectious Disease

·       GI Stool Testing

·       Autoimmune

·       Bone & Mineral

·       Cardiac Biomarkers

·       Others

By Type

·       Immunodiagnostic Instruments

·       Immunoassays

By Geography

·       North America

·       U.S.

·       Canada

·       Mexico

·       South America

·       Brazil

·       Argentina

·       Rest of South America

·       Europe

·       Germany

·       France

·       United Kingdom

·       Italy

·       Spain

·       Russia

·       Turkey

·       Belgium

·       Netherlands

·       Switzerland

·       Rest of Europe

·       Asia-Pacific

·       Japan

·       China

·       South Korea

·       India

·       Australia

·       Singapore

·       Malaysia

·       Indonesia

·       Thailand

·       Philippines

·       Rest of Asia-Pacific

·       Middle East and Africa

·       South Africa

·       Egypt

·       Saudi Arabia

·       United Arab Emirates

·       Israel

·       Rest of Middle East and Africa

Key Developments in the Market:

In March 2019, Oncimmune Holdings plc acquired Protagen Diagnostics AG. Protagen is a leader in drug development for both immuno-oncology and autoimmune disease. With this acquisition, Oncimmune along with its expertise in immunogenic product development would expand its client base by combining Protagen’s biomarker discovery capabilities, thereby accelerating product innovation and development process, bringing about advancements in immunodiagnostics.

In March 2016, DiaSorin S.p.A. in order to expand its client base, product portfolio, and presence in growing infectious disease molecular testing market acquired Focus Diagnostics' immunodiagnostic & molecular diagnostic products business from Quest Diagnostics. Therefore, with this acquisition there would be development and innovations in the immunodiagnostic and infectious disease market.

Competitive Analysis: Global Immunodiagnostics Market

Global immunodiagnostics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of immunodiagnostics market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors: Global Immunodiagnostics Market

Few of the major market competitors currently working in the immunodiagnostics market are Abbott., F. Hoffmann-La Roche Ltd, Danaher., Adaptive Biotechnologies., QIAGEN, AMARANTUS BIOSCIENCE HOLDINGS, INC., AESKU.GROUP GmbH & Co. KG, Avant Diagnostics, Inc., bioMérieux SA, Inova Diagnostics, Inc., OraSure Technologies, Myriad Genetics, Inc, Omega Diagnostics Group PLC, Nexus-Dx, Protagen, Quest Diagnostics Incorporated., Seramun Diagnostica GmbH., SQI Diagnostics, Tecan Trading AG, Siemens Healthcare GmbH, DiaSorin, Erba Diagnostics, Svar Life Science and Exagen Inc. amongst others.

Get full details of TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-immunodiagnostics-market

Reasons for Buying this Report

This report provides pin-point analysis for changing competitive dynamics

It provides a forward looking perspective on different factors driving or restraining market growth

It provides a six-year forecast assessed on the basis of how the market is predicted to grow

It helps in understanding the key product segments and their future

It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors

It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-immunodiagnostics-market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: [email protected]

Browse Related Reports @

Transcathetar Devices Market

Wearable Artificial Kidney Market